Ravi Nemivant, MD

Ravi Nemivant, MD
Pulmonary Disease · Naperville, IL

Ravi Nemivant, MD is a pulmonary disease in Naperville, IL with about 28 yrs in practice.

  • SpecialtyPulmonary Disease
  • Medical schoolRUSH MEDICAL COLLEGE OF RUSH UNIVERSITY (1998)
  • TelehealthOffers telehealth visits
  • Practice size1,328 clinicians
  • Medicare assignmentAccepts assignment (Medicare-approved amount as full payment)
  • Medicare activity~669 patients across 1,901 services, avg age 74

Common services

ServiceMedicare servicesMedicare allows
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more268$130See prices →
Test to measure expiratory airflow and volume changes before and after medication administration119$40See prices →
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more104$172See prices →
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more78$94See prices →
Sleep study in sleep lab with continuous airway pressure (6 years or older)61$665See prices →
Sleep study in sleep lab (6 years or older)50$634See prices →
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more25$220See prices →
Therapy procedure using a positive pressure ventilator14$66See prices →
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more12$116See prices →

Hospital affiliations

Source: CMS Medicare Physician & Other Practitioners and the Doctors & Clinicians National Downloadable File (most recent release). Counts reflect Original Medicare activity only and are not a measure of quality. “Medicare allows” is the Medicare fee schedule amount — not what an insured or cash patient pays; for patient prices see the linked procedure pages. Always confirm a clinician’s current details with their office.